Q98439691

Summary

Q98439691 is an interpellation^[1].

Key Facts

• Q98439691 authored Agneta Luttropp^[2].
• Q98439691's instance of is recorded as interpellation^[3].
• Q98439691's part of the series is recorded as interpellations of the 2012/13 legislative session of the Riksdag^[4].
• Q98439691's language of work or name is recorded as Swedish^[5].
• Q98439691's publication date is recorded as +2013-03-13T00:00:00Z^[6].
• Q98439691's significant event is recorded as debate^[7].
• Q98439691's main subject is recorded as medication^[8].
• Q98439691's work available at URL is recorded as http://data.riksdagen.se/dokument/H010329^[9].
• Q98439691's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H010329^[10].
• Q98439691's applies to jurisdiction is recorded as Sweden^[11].
• Q98439691's legal citation of this text is recorded as ip. 2012/13:329^[12].
• Q98439691's title is recorded as Åtgärder mot oetiska läkemedelsbedömningar^[13].
• Q98439691's addressee is recorded as Göran Hägglund^[14].
• Q98439691's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98439691's copyright status is recorded as public domain^[16].
• Q98439691's Swedish Riksdag document ID is recorded as H010329^[17].

Body

Works and Contributions

Q98439691 authored Agneta Luttropp^[2].